MMSI — Merit Medical Systems Income Statement
0.000.00%
- $5.59bn
- $5.93bn
- $1.36bn
- 92
- 26
- 80
- 73
Annual income statement for Merit Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 964 | 1,075 | 1,151 | 1,257 | 1,357 |
Cost of Revenue | |||||
Gross Profit | 401 | 485 | 519 | 584 | 643 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 965 | 1,014 | 1,063 | 1,133 | 1,201 |
Operating Profit | -1.56 | 60.9 | 87.6 | 124 | 156 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.2 | 53.9 | 82.6 | 112 | 150 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.474 | 1.07 | 1.44 | 1.72 | 2.14 |